Skip to main content

Table 1 Baseline characteristics of the 3963 individuals within the first interval for FG-CV quintiles

From: Visit-to-visit variability of glycemia and vascular complications: the Hoorn Diabetes Care System cohort

OutcomeAll with first intervalQ1Q2Q3Q4Q5P value
MeanCI25CI75MeanCI25CI75MeanCI25CI75MeanCI25CI75MeanCI25CI75MeanCI25CI75
N3963  792  793  792  793  793   
Sex (%)53  51  52  50  54  56  0.10
Age (years)61.654.269.363.556.670.463.456.670.961.65568.960.252.668.259.450.967.7≤ 0.001
Time since diagnosis1.10.91.21.10.91.21.111.21.10.91.21.10.91.21.10.91.2≤ 0.001
BMI (kg/m2)30.126.532.929.125.931.63026.532.830.226.532.930.426.733.530.826.733.8≤ 0.001
HbA1c (%)6.7676.35.96.66.466.76.66.16.96.86.17.27.66.48.3≤ 0.001
HbA1c (mmol/mol)50.042.55345.24148.646.34249.748.34351.950.843.25559.34667.2≤ 0.001
Glucose (mmol/L)7.86.78.47.16.47.67.46.68.17.66.78.27.86.88.78.9710.2≤ 0.001
HDL (mmol/L)1.211.41.31.11.51.311.51.211.41.211.41.211.3≤ 0.001
LDL (mmol/L)3.02.23.62.92.23.632.23.632.23.632.23.632.33.60.39
Triaglycerol (mmol/L)1.91.22.21.71.121.81.22.11.91.22.21.91.22.32.21.32.5≤ 0.001
SBP (mmHg)141.7128154141.7128153143.5130156142.2128154140.8126.2153140.21271520.01
DBP (mmHg)80.1738679.7738579.7738679.9738780.7748780.77488≤ 0.01
Metformin (%)54  48  53  52  58  58  0.01
Sulfonylureas (%)25  14  18  20  31  42  ≤ 0.001
Insulin (%)5  2  2  3  5  12  ≤ 0.001
Other glucose lowering drugs (%)2  1  2  1  2  2  0.26
ACE50.1  50.4  52.8  49.1  51.3  50.4  0.65
ARB73.9  75.0  74.1  75.4  74.7  70.2  0.13
Smoking,  % yes19.9  16.2  16.0  19.7  21.6  26.0  ≤ 0.001
% no67.1  68.9  68.6  67.3  66.3  64.1   
% former10.8  12.1  13.0  10.6  10.6  7.8   
% unknown2.2  2.8  2.4  2.4  1.5  2.1   
European descent (%)90.4  92.9  91.4  89.7  90.3  87.9  0.09